Impact of Key Nicotinic AChR Subunits on Post-Stroke Pneumococcal Pneumonia.
Sandra JagdmannClaudia DamesDaniel BerchtoldKatarzyna WinekLuis WeitbrechtAndreas MeiselChristian MeiselPublished in: Vaccines (2020)
Pneumonia is the most frequent severe medical complication after stroke. An overactivation of the cholinergic signaling after stroke contributes to immunosuppression and the development of spontaneous pneumonia caused by Gram-negative pathogens. The α7 nicotinic acetylcholine receptor (α7nAChR) has already been identified as an important mediator of the anti-inflammatory pathway after stroke. However, whether the α2, α5 and α9/10 nAChR expressed in the lung also play a role in suppression of pulmonary innate immunity after stroke is unknown. In the present study, we investigate the impact of various nAChRs on aspiration-induced pneumonia after stroke. Therefore, α2, α5, α7 and α9/10 nAChR knockout (KO) mice and wild type (WT) littermates were infected with Streptococcus pneumoniae (S. pneumoniae) three days after middle cerebral artery occlusion (MCAo). One day after infection pathogen clearance, cellularity in lung and spleen, cytokine secretion in bronchoalveolar lavage (BAL) and alveolar-capillary barrier were investigated. Here, we found that deficiency of various nAChRs does not contribute to an enhanced clearance of a Gram-positive pathogen causing post-stroke pneumonia in mice. In conclusion, these findings suggest that a single nAChR is not sufficient to mediate the impaired pulmonary defense against S. pneumoniae after experimental stroke.
Keyphrases
- gram negative
- wild type
- multidrug resistant
- middle cerebral artery
- pulmonary hypertension
- community acquired pneumonia
- anti inflammatory
- respiratory failure
- healthcare
- type diabetes
- intensive care unit
- internal carotid artery
- candida albicans
- oxidative stress
- atomic force microscopy
- high resolution
- endothelial cells
- respiratory tract
- single molecule
- replacement therapy
- mechanical ventilation